ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page |
||||||
PART I |
||||||
Item 1. |
4 | |||||
Item 1A. |
22 | |||||
Item 1B. |
58 | |||||
Item 2. |
58 | |||||
Item 3. |
58 | |||||
Item 4. |
58 | |||||
PART II |
||||||
Item 5. |
59 | |||||
Item 6. |
60 | |||||
Item 7. |
60 | |||||
Item 7A. |
62 | |||||
Item 8. |
62 | |||||
Item 9. |
62 | |||||
Item 9A. |
62 | |||||
Item 9B. |
63 | |||||
Item 9C. |
63 | |||||
PART III |
||||||
Item 10. |
64 | |||||
Item 11. |
72 | |||||
Item 12. |
72 | |||||
Item 13. |
74 | |||||
Item 14. |
76 | |||||
PART IV |
||||||
Item 15. |
77 | |||||
Item 16. |
78 |
• | our ability to complete our initial business combination; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our ability to consummate an initial business combination due to the uncertainty resulting from the COVID-19 pandemic and the ongoing military conflict between Russia and Ukraine; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | the ability of our officers and directors to generate a number of potential investment opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; or |
• | our future financial performance. |
• | “amended and restated certificate of incorporation” are to the amended and restated certificate of incorporation of the company; |
• | “Class A common stock” are to our Class A common stock, par value $0.0001 per share; |
• | “Class B founder shares” are to shares of our Class B common stock, par value $0.0001 per share, initially issued to our sponsor in a private placement prior to our IPO and the shares of our Class A common stock that will be issued upon the automatic conversion of the shares of our Class B common stock at the time of our initial business combination (for the avoidance of doubt, such shares of our Class A common stock are not “public shares”); |
• | “Class K founder shares” are to shares of our Class K common stock, par value $0.0001 per share, sold to our sponsor in a private placement prior to the closing of our IPO and the shares of Class A common stock that will be issued upon the automatic conversion of the shares of Class K common stock only to the extent certain triggering events occur prior to the 10th anniversary of our initial business combination, including specified strategic transactions and other triggering events based on our stock trading at $30.00 per share and additional stock trading thresholds up to $50.00 per share (for the avoidance of doubt, such shares of Class A common stock are not “public shares”); |
• | “combination period” are to the period until March 26, 2023 (24 months from the closing of our IPO), or until June 26, 2023 (27 months from the closing of our IPO) if we have executed a letter of intent, agreement in principle or definitive agreement for an initial business combination by March 26, 2023; |
• | “common stock” are to our Class A common stock, our Class B common stock and our Class K common stock, collectively; |
• | “DGCL” are to the Delaware General Corporation Law as the same may be amended from time to time; |
• | “equity-linked securities” are to any debt or equity securities that are convertible into, or exercisable or exchangeable for, shares of our Class A common stock issued in connection with our initial business combination including but not limited to a private placement of equity or debt; |
• | “founders” are to Vinod Khosla, Samir Kaul and David Weiden; |
• | “founder shares” are to our Class B founder shares and Class K founder shares, collectively; |
• | “forward-purchase shares” are to shares of our Class A common stock to be issued to the Khosla Entities pursuant to the forward-purchase agreement; |
• | “initial stockholders” are to our sponsor and any other holders of our founder shares prior to our IPO; |
• | “IPO” is to our initial public offering of our Class A common stock which closed on March 26, 2021; |
• | “Khosla” are to Khosla Ventures, a leading venture capital firm that invests in high technology companies; |
• | “Khosla Entities” are to our sponsor and any successor or assigns of our sponsor, if any, under the forward-purchase agreement; |
• | “management” or our “management team” are to our executive officers and directors; |
• | “private placement shares” are the shares issued to our sponsor in a private placement simultaneously with the closing of our IPO (for the avoidance of doubt, such private placement shares are not “public shares”); |
• | “public shares” are to shares of our Class A common stock sold in connection with our IPO; |
• | “public stockholders” are to the holders of our public shares, including our sponsor and management team to the extent our sponsor and/or members of our management team purchase public shares, provided that our sponsor’s and each member of our management team’s status as a “public stockholder” will only exist with respect to such public shares; |
• | “specified future issuance” are to an issuance of a class of equity or equity-linked securities to specified purchasers that we may determine to make in connection with financing our initial business combination; |
• | “sponsor” are to Khosla Ventures SPAC Sponsor III LLC, a Delaware limited liability company, in which certain of our officers and directors are beneficial owners; |
• | “trust account” are to the trust account in the United States, with Continental Stock Transfer & Trust Company, LLC acting as trustee, into which we deposited certain proceeds from our IPO and the sale of the private placement shares; and |
• | “we,” “us,” “our,” “company” or “our company” refer to Khosla Ventures Acquisition Co. III, a Delaware corporation. |
• | Large and Growing Addressable Market : |
• | Proprietary Technology Advantage |
• | Scaling Business with Compelling Growth Opportunity: |
• | World Class Management Teams: |
• | Be Bold Early and Impactful: |
• | Short Innovation Cycles: |
• | Long Investment Horizon: |
• | Opportunity to be Additive: |
• | subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and |
• | cause us to depend on the marketing and sale of a single product or limited number of products or services. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
• | file proxy materials with the SEC. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
• | Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.” |
• | We may not be able to complete our initial business combination within the combination period, in which case we would cease all operations except for the purpose of winding up, and we would redeem our public shares for a pro rata portion of the funds in the trust account, and we would liquidate. |
• | Your only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek stockholder approval of such business combination. |
• | Our initial stockholders will control a substantial interest in us and thus may influence certain actions requiring a stockholder vote. |
• | We may not obtain a fairness opinion with respect to the target business that we seek to acquire and therefore you may be relying solely on the judgment of our board of directors in approving a proposed business combination. |
• | We may issue additional shares of capital stock or debt securities to complete a business combination, which would reduce the equity interest of our stockholders and likely cause a change in control of our ownership. |
• | We may be unable to obtain additional financing, if required, to complete a business combination or to fund the operations and growth of the target business. |
• | Resources could be wasted in researching acquisitions that are not consummated, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. |
• | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the recent coronavirus (COVID-19) pandemic, the ongoing military conflict between Russia and Ukraine and other events, and the status of debt and equity markets. |
• | We have identified a material weakness in our internal control over financial reporting. |
• | We may have a limited ability to assess the management of a prospective target business and, as a result, may consummate our initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company. |
• | There may be tax consequences to our initial business combination that may adversely affect us. |
• | Our officers and directors presently have fiduciary or contractual obligations to other entities and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. |
• | Our officers and directors may have interests in a potential business combination that are different than yours, which may create conflicts of interest. |
• | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | As a result of the issuance of Class B and Class K shares of our common stock to our sponsor at a nominal price, you will experience immediate and substantial dilution from the purchase of Class A shares of our common stock. |
• | If third parties bring claims against us, and if our directors decide not to enforce the indemnification obligations of our sponsor, or if our sponsor does not have the funds to indemnify us, the proceeds held in the trust account could be reduced and the per share redemption amount received by stockholders may be less than $10.00 per share. |
• | Provisions in our amended and restated certificate of incorporation and bylaws and Delaware law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our common stock and could entrench management. |
• | Our stockholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares. |
• | We may not hold an annual meeting of stockholders until after the consummation of our initial business combination. |
• | We are a newly formed company with no operating history, and, accordingly, you have no basis on which to evaluate our ability to achieve our business objective. |
• | If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination. |
• | We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging growth companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies. |
• | Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption and/or financial loss. |
• | restrictions on the nature of our investments; and |
• | restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. |
• | registration as an investment company; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
• | may significantly dilute the equity interest of investors; |
• | may subordinate the rights of holders of our Class A common stock if share of preferred stock are issued with rights senior to those afforded our Class A common stock; |
• | could cause a change in control if a substantial number of shares of our Class A common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and |
• | may adversely affect prevailing market prices for our public shares. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; |
• | our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding; |
• | our inability to pay dividends on our Class A common stock; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions and fund other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements and execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
• | costs and difficulties inherent in managing cross-border business operations and complying with different commercial and legal requirements of overseas markets; |
• | rules and regulations regarding currency redemption; |
• | complex corporate withholding taxes on individuals; |
• | laws governing the manner in which future business combinations may be effected; |
• | exchange listing and/or delisting requirements; |
• | tariffs and trade barriers; |
• | regulations related to customs and import/export matters; |
• | local or regional economic policies and market conditions; |
• | unexpected changes in regulatory requirements; |
• | longer payment cycles; |
• | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
• | currency fluctuations and exchange controls; |
• | rates of inflation; |
• | challenges in collecting accounts receivable; |
• | cultural and language differences; |
• | employment regulations; |
• | underdeveloped or unpredictable legal or regulatory systems; |
• | corruption; |
• | protection of intellectual property; |
• | social unrest, crime, strikes, riots and civil disturbances; |
• | regime changes and political upheaval; |
• | terrorist attacks, natural disasters and wars; |
• | deterioration of political relations with the United States; and |
• | government appropriation of assets. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | 20% at $20.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period (the “First Price Vesting”); |
• | 25% at $25.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period (the “Second Price Vesting”); and |
• | 30% at $30.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period (the “Third Price Vesting”). |
• | if (and only if) the First Price Vesting shall not have occurred prior to or in connection with such Strategic Transaction and the effective price of the Strategic Transaction is greater than $15.00 per share and less than or equal to $20.00 per share, the applicable aggregate percentage of founder shares would be equal to (i) 15% plus (ii) the product of 5% multiplied by a fraction, the numerator of which is equal to $20.00 minus the effective price of the Strategic Transaction and the denominator of which is $5.00 (each as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like); |
• | if (and only if) the Second Price Vesting shall not have occurred prior to or in connection with such Strategic Transaction and the effective price of the Strategic Transaction is greater than $20.00 per share and less than or equal to $25.00 per share, the applicable aggregate percentage of founder shares would be equal to (i) 20% plus (ii) the product of 5% multiplied by a fraction, the numerator of which is equal to $25.00 minus the effective price of the Strategic Transaction and the denominator of which is $5.00 (each as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like); |
• | if (and only if) the Third Price Vesting shall not have occurred prior to or in connection with such Strategic Transaction and the effective price of the Strategic Transaction is greater than $25.00 per share and less than or equal to $30.00 per share (a “Third Strategic Transaction Price Vesting Event”), the applicable aggregate percentage of founder shares would be equal to (i) 25% plus (ii) the product of 5% multiplied by a fraction, the numerator of which is equal to $30.00 minus the effective price of the Strategic Transaction and the denominator of which is $5.00 (each as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like); and |
• | if (and only if) the Third Price Vesting shall not have occurred prior to or in connection with such Strategic Transaction and the effective price of the Strategic Transaction is greater than $30.00, then the applicable aggregate percentage of founder shares would be equal to 30%. |
Name |
Age |
Position | ||
Samir Kaul |
48 | Chief Executive Officer, Director | ||
Peter Buckland |
52 | Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary | ||
Loren Bough |
50 | Director | ||
Sara Clemens |
53 | Director | ||
Harrison Frist |
38 | Director |
• | appointing, compensating and overseeing our independent registered public accounting firm; |
• | reviewing and approving the annual audit plan for the company; |
• | overseeing the integrity of our financial statements and our compliance with legal and regulatory requirements; |
• | discussing the annual audited financial statements and unaudited quarterly financial statements with management and the independent registered public accounting firm; |
• | pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed; |
• | appointing or replacing the independent registered public accounting firm; |
• | establishing procedures for the receipt, retention and treatment of complaints (including anonymous complaints) we receive concerning accounting, internal accounting controls, auditing matters or potential violations of law; |
• | monitoring our environmental sustainability and governance practices; |
• | establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; |
• | approving audit and non-audit services provided by our independent registered public accounting firm; |
• | discussing earnings press releases and financial information provided to analysts and rating agencies; |
• | discussing with management our policies and practices with respect to risk assessment and risk management; |
• | reviewing any material transaction between our Chief Financial Officer that has been approved in accordance with our Code of Ethics for our officers, and providing prior written approval of any material transaction between us and our President; and |
• | producing an annual report for inclusion in our proxy statement, in accordance with applicable rules and regulations. |
• | reviewing and approving corporate goals and objectives relevant to our President’s compensation, evaluating our President’s performance in light of those goals and objectives, and setting our President’s compensation level based on this evaluation; |
• | setting salaries and approving incentive compensation and equity awards, as well as compensation policies, for all other officers who file reports of their ownership, and changes in ownership, of the company’s common stock under Section 16(a) of the Exchange Act (the “Section 16 Officers”), as designated by our board of directors; |
• | making recommendations to the board of directors with respect to incentive compensation programs and equity-based plans that are subject to board approval; |
• | approving any employment or severance agreements with our Section 16 Officers; |
• | granting any awards under equity compensation plans and annual bonus plans to our President and the Section 16 Officers; |
• | approving the compensation of our directors; and |
• | producing an annual report on executive compensation for inclusion in our proxy statement, in accordance with applicable rules and regulations. |
• | identifying individuals qualified to become members of the board of directors and making recommendations to the board of directors regarding nominees for election; |
• | reviewing the independence of each director and making a recommendation to the board of directors with respect to each director’s independence; |
• | developing and recommending to the board of directors the corporate governance principles applicable to us and reviewing our corporate governance guidelines at least annually; |
• | making recommendations to the board of directors with respect to the membership of the audit, compensation and corporate governance and nominating committees; |
• | overseeing the evaluation of the performance of the board of directors and its committees on a continuing basis, including an annual self-evaluation of the performance of the corporate governance and nominating committee; |
• | considering the adequacy of our governance structures and policies, including as they relate to our environmental sustainability and governance practices; |
• | considering director nominees recommended by stockholders; and |
• | reviewing our overall corporate governance and reporting to the board of directors on its findings and any recommendations. |
• | should possess personal qualities and characteristics, accomplishments and reputation in the business community; |
• | should have current knowledge and contacts in the communities in which we do business and in our industry or other industries relevant to our business; |
• | should have the ability and willingness to commit adequate time to the board of directors and committee matters; |
• | should demonstrate ability and willingness to commit adequate time to the board of directors and committee matters; |
• | should possess the fit of the individual’s skills and personality with those of other directors and potential directors in building a board of directors that is effective, collegial and responsive to our needs; and |
• | should demonstrate diversity of viewpoints, background, experience, and other demographics, and all aspects of diversity in order to enable the board of directors to perform its duties and responsibilities effectively, including candidates with a diversity of age, gender, nationality, race, ethnicity, and sexual orientation. |
• | the corporation could financially undertake the opportunity; |
• | the opportunity is within the corporation’s line of business; and |
• | it would not be fair to our company and its stockholders for the opportunity not to be brought to the attention of the corporation. |
Individual |
Entity |
Entity’s Business |
Affiliation | |||
Vinod Khosla |
Khosla Ventures(1) |
Technology |
Founder | |||
KV Acquisition I(2) |
Blank Check Company |
Founder | ||||
Samir Kaul |
Khosla Ventures(1) |
Technology |
Managing Director, General Partner | |||
KV Acquisition I(2) |
Blank Check Company |
President, Chief Executive Officer and Director | ||||
Jack Creek Investment Corp. |
Blank Check Company |
Director | ||||
|
|
| ||||
Peter Buckland |
Khosla Ventures(1) |
Technology |
Managing Director, General Partner and Chief Operating Officer | |||
KV Acquisition I(2) |
Blank Check Company |
Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary | ||||
Sara Clemens |
Twitch |
Technology |
Chief Operating Officer | |||
Hootsuite |
Technology |
Director | ||||
Duolingo |
Technology |
Director | ||||
|
|
| ||||
Loren Bough |
Prescient Co Inc. |
Construction |
Director | |||
Big Sky Investment Holdings |
Financial Services |
Director | ||||
Taurus Investment Holdings |
Financial Services |
Director | ||||
|
|
| ||||
Harrison Frist |
naviHealth |
Healthcare |
President, Operations | |||
|
|
|
(1) | Includes Khosla Ventures and certain of its funds and other affiliates including affiliated portfolio companies. |
(2) | These entities’ amended and restated certificates of incorporation contain a waiver of the corporate opportunity doctrine. Accordingly, there are no conflicting obligations to bring opportunities to these entities before the Company. |
• | Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers and directors is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our executive officers and directors are not obligated to contribute any specific number of hours per week to our affairs. |
• | Our sponsor, directors and each member of our management team have entered into agreements with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares and any public shares held by them in connection with (i) the completion of our initial business combination and (ii) a stockholder vote to approve an amendment to our amended and restated certificate of incorporation that would affect the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we have not completed an initial business combination within the combination period. Additionally, our sponsor has agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we do not complete our initial business combination within the prescribed time frame. Except as described herein, our sponsor and our directors and executive officers have agreed not to transfer, assign or sell (i) any of their Class B founder shares (and any shares of our Class A common stock issuable upon conversion thereof) until the earlier to occur of: (A) one year after the completion of our initial business combination or (B) subsequent to our initial business combination, (x) if the last sale price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property and (ii) any of their shares of Class K common stock for any reason, other than to specified permitted transferees or subsequent to our initial business combination in connection with a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property; provided, that any shares of Class A commons stock issued upon conversion of any shares of Class K common stock will not be subject to such restrictions on transfer. |
• | The private placement shares acquired by our sponsor will not be transferable until 30 days following the completion of our initial business combination. Because certain of our executive officers and directors will own common stock directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. |
• | Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors is included by a target business as a condition to any agreement with respect to our initial business combination. |
• | each person known by us to be the beneficial owner of more than 5% of our outstanding shares of Class A common stock; |
• | each of our executive officers and directors that beneficially owns shares of common stock; and |
• | all our executive officers and directors as a group. |
Name and Address of Beneficial Owner(1) |
Number of Shares Beneficially Owned(2)(3) |
Percentage of Outstanding Common Stock |
||||||
O UR SPONSOR , DIRECTORS AND EXECUTIVE OFFICERS |
||||||||
Khosla Ventures SPAC Sponsor III LLC (our sponsor)(4) |
11,128,656 | 16.5 | % | |||||
Vinod Khosla(4) |
11,128,656 | 16.5 | % | |||||
Samir Kaul(4) |
11,128,656 | 16.5 | % | |||||
Peter Buckland |
— | — | ||||||
Sara Clemens |
79,525 | * | ||||||
Loren Bough |
79,525 | * | ||||||
Harrison Frist |
79,525 | * | ||||||
All executive officers, directors and director nominees as a group (5 individuals) |
11,367,231 | 16.8 | % |
* | less than 1%. |
(1) | Unless otherwise noted, the business address of each of the following entities or individuals is c/o Khosla Ventures Acquisition Co., 2128 Sand Hill Road, Menlo Park, CA 94025. |
(2) | Our sponsor holds 1,300,000 shares of Class A common stock purchased in the private placement at the time of our IPO, an additional 126,605 shares of Class A common stock purchased in connection with the underwriters’ partial exercise of their over-allotment option and 4,880,000 shares of Class B common stock purchased from us prior to our IPO. Each of our independent directors, Ms. Clemens, Mr. Bough and Mr. Frist, holds 40,000 shares of Class B common stock transferred to him or her by our sponsor prior to our IPO at the original purchase price. On the first day following the completion of our business combination, the Class B founder shares will automatically convert into a number of shares of our Class A common stock equal to 15% of the sum of (i) the total number of all shares of Class A common stock issued and outstanding upon completion of our IPO (including any overallotment shares if the underwriters exercise their overallotment option), plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion of the Class B founder shares plus (iii) unless waived, the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination, excluding (x) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial business combination, (y) any shares of Class A common stock issuable upon conversion of the Class K founder shares and (z) any private placement shares. If calculated based on the public shares outstanding as of immediately after our IPO the shares of Class B common stock would be convertible (on the first day following the completion of our business combination) into an aggregate of 9,940,627 shares of Class A common stock, of which 9,702,052 would be held by our sponsor and 79,525 would be held by each of our independent directors. |
(3) | Does not include shares of Class A common stock that may be issuable upon conversion of the 5,000,000 shares of Class K common stock, which amount would be up to 13,254,170 shares of Class A common stock as of immediately after our IPO. The Class K founder shares are non-voting and will convert into shares of Class A common stock after our initial business combination, subject to adjustment pursuant to certain anti-dilution rights, as described herein, but only to the extent certain triggering events occur prior to the 10th anniversary of our initial business combination including three equal triggering events based on our stock trading at $20.00, $25.00 and $30.00 per share following the first anniversary of the closing of our initial business combination and also upon specified strategic transactions. Notwithstanding the foregoing, all shares of Class K common stock that are issued and outstanding on the 10th anniversary of our initial business combination will be automatically forfeited. |
(4) | Khosla Ventures SPAC Sponsor Services LLC is the owner of Khosla Ventures SPAC Sponsor III LLC. Vinod Khosla and Samir Kaul are the joint managers of Khosla Ventures SPAC Sponsor Services LLC, and indirectly own equity interests in Khosla Ventures SPAC Sponsor Services LLC through VK Services LLC and SK SPAC Services, LLC, respectively. As such, each of VK Services LLC, SK SPAC Services, LLC and Messrs. Khosla and Kaul may be deemed to share beneficial ownership of the shares held directly by our sponsor. |
Incorporated by Reference |
Filed/ |
|||||||||||||||||||||
Exhibit Number |
Exhibit Description |
Form |
File No. |
Exhibit |
Filing Date |
Furnished Herewith |
||||||||||||||||
31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a). | * | ||||||||||||||||||||
32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350. | * | * | |||||||||||||||||||
32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350. | * | * | |||||||||||||||||||
101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | * | ||||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | * | ||||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | * | ||||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | * | ||||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | * | ||||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | * |
* | Filed herewith. |
** | Furnished herewith. |
KHOSLA VENTURES ACQUISITION CO. III | ||||||
Date: March 31, 2022 |
By: |
/s/ Samir Kaul | ||||
Samir Kaul | ||||||
Chief Executive Officer and President |
Name |
Title |
Date | ||
/s/ Samir Kaul | Chief Executive Officer, President and Director |
March 31, 2022 | ||
Samir Kaul |
( Principal Executive Officer |
|||
/s/ Peter Buckland | Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary |
March 31, 2022 | ||
Peter Buckland |
( Principal Financial Officer and Principal Accounting Officer) |
|||
/s/ Loren Bough | Director |
March 31, 2022 | ||
Loren Bough |
||||
/s/ Sara Clemens | Director |
March 29, 2022 | ||
Sara Clemens |
||||
/s/ Harrison Frist | Director |
March 31, 2022 | ||
Harrison Frist |
Page |
||||
F-2 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
F-7 | ||||
F-8 |
/S/ BDO USA, LLP |
We have served as the Company’s auditor since 2021. |
March 31, 2022 |
ASSETS |
| |||
Cash and cash equivalents |
$ | |||
Prepaid expenses |
||||
|
|
|||
Total current assets |
||||
Marketable securities held in Trust Account |
||||
Other assets |
||||
|
|
|||
Total Assets |
$ |
|||
|
|
|||
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ DEFICIT |
| |||
Current liabilities: |
| |||
Accounts payable |
$ | |||
Due to related party |
||||
Franchise tax payable |
||||
Accrued expenses |
||||
|
|
|||
Total current liabilities |
||||
Deferred underwriting fees payable |
||||
Class K Founder Shares derivative liabilities |
||||
|
|
|||
Total liabilities |
||||
|
|
|||
Commitments and Contingencies (Note 6) |
| |||
Class A common stock subject to possible redemption, |
||||
Stockholders’ deficit |
| |||
Preferred stock, $ |
||||
Class A common stock, $ |
||||
Class B common stock. $ |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
|
|
|||
Total stockholders’ deficit |
( |
) | ||
|
|
|||
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders’ Deficit |
$ |
|||
|
|
Formation costs |
$ | |||
General and administrative expenses |
||||
Franchise tax expense |
||||
|
|
|||
Loss from operations |
( |
) | ||
Financing expenses on derivative classified instrument |
( |
) | ||
Change in fair value of derivative warrant liabilities |
||||
Gain on marketable securities (net), dividends and interest, held in Trust Account |
||||
|
|
|||
Net loss |
$ | ( |
) | |
|
|
|||
Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted |
||||
Basic and diluted net loss per share, Class A common stock subject to possible redemption |
$ |
( |
) | |
Weighted average shares outstanding of Class A non-redeemable common stock, basic and diluted |
||||
Basic and diluted net loss per share, Class A non-redeemable common stock |
$ |
( |
) | |
Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted |
||||
Basic and diluted net loss per share, Class B non-redeemable common stock |
$ |
( |
) |
Common Stock Subject to Possible Redemption |
Common Stock |
|||||||||||||||||||||||||||||||||||||
Class A |
Class A |
Class B |
||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Additional Paid-In Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||||||||
Balance as of January 29, 2021 (Inception) |
$ | |
|
— | $ | — | $ |
$ | $ | $ | ||||||||||||||||||||||||||||
Issuance of common stock to Sponsor |
— | — | |
|
— | — | — | |||||||||||||||||||||||||||||||
Sale of Public Shares, net of $ costs |
|
|
— | — | — | — | — | — | ||||||||||||||||||||||||||||||
Sale of Private Placement Shares |
— | — | |
|
— | — | — | |||||||||||||||||||||||||||||||
Accretion of Class A Common Stock to redemption value |
— | |
|
— | — | — | — | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||
Net loss |
— | — | |
|
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance as of December 31, 2021 |
$ |
|
|
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities |
||||
Net Loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
Finance expenses on derivative classified instrument |
||||
Gain on marketable securities (net), dividends and interest, held in Trust Account |
( |
) | ||
Change in fair value of derivative liabilities |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses and other assets |
( |
) | ||
Accounts payable, franchise tax payable and accrued expenses |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities |
||||
Investment of cash into Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities |
||||
Proceeds from issuance of Class B and Class K common stock to Sponsor |
||||
Advances from related party |
||||
Proceeds from sale of Public Shares, net of transaction costs paid |
||||
Proceeds from sale of Private Placement Shares |
||||
Net cash provided by financing activities |
||||
Net increase in cash |
||||
Cash—beginning of period |
||||
Cash—end of period |
$ | |||
Supplemental disclosure of noncash investing and financing activities: |
||||
Accretion of Class A Common Stock to redemption value |
$ | |||
Deferred underwriting fees payable |
$ |
• | Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
• | Level 2: Observable inputs other than Level 1 inputs. Example of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
• | Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
For The Period From January 29, 2021 Through December 31, 2021 |
||||
|
|
|||
Net loss from January 29, 2021 |
$ |
( |
) | |
Accretion of temporary equity in excess of fair value |
( |
) | ||
|
|
|||
Net loss including accretion of temporary equity in excess of fair value |
$ | ( |
) | |
|
|
For The Period From January 29, 2021 (Inception) Through December 31, 2021 |
||||||||||||
Class A-t |
Class A-p |
Class B |
||||||||||
Basic and diluted net loss per share |
||||||||||||
Numerator |
||||||||||||
Allocation of net loss including accretion of temporary equity in excess of fair value |
$ |
( |
) | $ |
( |
) | $ |
( |
) | |||
Deemed dividend for accretion of temporary equity in excess of fair value |
— | — | ||||||||||
|
|
|
|
|
|
|||||||
Allocation of net loss and deemed dividends |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
|||||||
Denominator |
||||||||||||
Weighted average shares outstanding, basic and diluted |
||||||||||||
Basic and diluted net loss per share |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||
Assets |
||||||||||||||||
Marketable securities held in Trust Account |
$ | $ | — | $ | — | $ | ||||||||||
Liabilities: |
| |||||||||||||||
Derivative liability - Class K Founder Shares |
— | — |
Input |
January 29, 2021 (Inception) |
December 31, 2021 |
||||||
Risk-free interest rate |
% | % | ||||||
Term to business combination |
||||||||
Expected volatility |
% | % | ||||||
Stock price |
$ | $ | ||||||
Dividend yield |
% | % |
Class K Founder Shares Derivative Liabilities |
Total |
|||||||
Fair value at January 29, 2021 (Inception) |
$ | $ | ||||||
Change in fair value |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Fair value as of |
$ | $ | ||||||
|
|
|
|
Current |
||||
Federal |
$ | |||
State |
||||
Deferred |
||||
Federal |
( |
) | ||
State |
||||
Valuation allowance |
||||
|
|
|||
Income tax provision |
$ | |||
|
|
Deferred tax assets |
| |||
Organization Costs |
$ | |||
Net operating loss carryforward |
||||
|
|
|||
Total deferred tax assets |
||||
Valuation allowance |
( |
) | ||
|
|
|||
Deferred tax assets, net of allowance |
$ | |||
|
|
Statutory federal income tax rate |
% | |||
Change in FMV of warrant liabilities |
% | |||
Non-deductible transaction costs |
( |
)% | ||
Change in valuation allowance |
( |
)% | ||
|
|
|||
Effective Tax Rate |
% | |||
|
|